Now scheduling product demos

Medical Affairs
Intelligence, Reimagined

MedAptive AI transforms how Medical Affairs teams capture field insights, track KOL relationships, and monitor competitive signals — from reactive and manual to adaptive and intelligent.

Request a Demo See the Platform →
app.medaptive.ai / dashboard
Medical Affairs Intelligence
Last updated: 2 hours ago · Q1 2025 · Oncology Portfolio
● LIVE
INSIGHTS THIS WEEK
147
↑ 23 from last week
TOP KOLS TRACKED
84
↑ 6 new profiles
COMP. SIGNALS
12
3 require review
MSL SUBMISSIONS
96%
↑ 4% vs avg
Top Field Themes
Dosing flexibility
42
Safety profile q's
31
Real-world data gaps
22
Competitor comparison
14
KOL Engagement Status
DK
Dr. D. Kim
Oncology · MSKCC
94
SR
Dr. S. Rao
Heme · Mayo Clinic
81
ML
Dr. M. Liu
Oncology · MD Anderson
78
JW
Dr. J. Walsh
Oncology · Dana-Farber
52
147 field insights captured this week
KOL sentiment trending positive across oncology portfolio
3 new competitor trial registrations detected
Cross-MSL theme: real-world data gaps rising 34% month-over-month
96% MSL insight submission rate vs 60% industry average
Weekly Insights Brief delivered to MA leadership in 2 hours vs 6 weeks
147 field insights captured this week
KOL sentiment trending positive across oncology portfolio
3 new competitor trial registrations detected
Cross-MSL theme: real-world data gaps rising 34% month-over-month
96% MSL insight submission rate vs 60% industry average
Weekly Insights Brief delivered to MA leadership in 2 hours vs 6 weeks

Medical Affairs is flying blind.

Your MSLs generate the most valuable intelligence in the company. Today, almost none of it reaches leadership in time to matter.

01
Field insights die in inboxes MSL notes live in Salesforce fields, Word docs, and email — never synthesized, never surfaced to leadership.
02
KOL "intelligence" is just a contact list Today's KOL tools don't tell you who's shifting opinion, who's citing your competitor, or who's about to keynote ASCO.
03
Competitive signals arrive too late By the time competitor trial data reaches your MSLs, HCPs have already formed their opinions.
04
The feedback loop to strategy never closes What HCPs say in the field should inform your evidence generation plan. Today it takes 6–18 months and a lot of filtering.
6wk
Average time for field insights to reach MA leadership after a congress
~40%
Of MSL field insights never make it into any structured system at all
$800K
Average annual spend on MA services — with no intelligence platform to show for it

Five pillars. One adaptive intelligence engine.

MedAptive AI is purpose-built for Medical Affairs — not adapted from a CRM or general-purpose analytics tool.

🎯
KOL Intelligence
Adaptive profiles that combine publication velocity, congress activity, trial PI roles, citation networks, and live MSL field sentiment. Scores update automatically. Know who to engage — and when.
📡
Competitive Signals
Continuous monitoring of ClinicalTrials.gov, FDA label changes, competitor publications, and congress presentations. Field-reported competitor mentions from MSLs layered in. Alerts before your competitors' data shapes HCP opinion.
📊
Strategic Dashboard
Executive and MSL manager views that connect field intelligence to strategy. Top emerging themes, KOL engagement gaps, competitive landscape shifts — in a single dashboard, updated weekly.
🤖
MSL Enablement AI
AI-generated pre-call briefings, on-demand literature synthesis, and post-call note generation. Reduces MSL scientific prep time by an estimated 60–70% per engagement.

From field conversation
to strategic action.

Five steps. Automated. Continuous. Adaptive.

📝
MSL Capture
Field notes, free text, or file upload. Structured form or voice (coming soon). Low-friction — under 3 minutes per engagement.
🧠
AI Extraction
NLP pipeline classifies sentiment, unmet needs, competitive mentions, and scientific questions against the MA taxonomy. MSL reviews and confirms.
🔗
Pattern Detection
Cross-MSL theme analysis identifies emerging trends. Signals that appear across multiple reps are flagged and scored for strategic significance.
📈
KOL Scoring
Adaptive influence scores and engagement status update automatically with each new field report and external data refresh.
🎯
Leadership Action
Weekly Insights Brief delivered to MA leadership. Executive dashboard updated. Evidence plan gaps surfaced for strategic review.

Built for pharma's
compliance requirements.

We built the security posture before we built the product. Because in pharma, that's not a checkbox — it's a sales requirement.

🔒
Architecturally Isolated
Each client's data lives in a completely separate database schema with row-level security. Not a policy — an architectural guarantee. Client A cannot see Client B's data under any circumstances.
🚫
We Never Train on Your Data
Our AI runs through Anthropic's enterprise API with zero data retention by default. Your proprietary field intelligence is never used to train any model — ours or anyone else's. This is in the contract.
📋
Full Audit Trail
Every data access, export, and API call is logged with user ID, timestamp, and action. You can audit who accessed what and when — which is what your compliance team actually needs.
🏥
BAA-Ready from Day One
We sign a Business Associate Agreement before you onboard. Our full infrastructure stack — cloud, database, AI API — is HIPAA-ready with a clean, verifiable chain.
Security Posture
What your legal team will find when they review our vendor documentation.
AES-256 encryption at rest + TLS 1.3 in transit
US data residency (default); EU residency on roadmap
Role-based access control (MSL / Manager / VP / Admin)
SOC 2 Type II certification in progress
Zero PHI storage policy (prohibited in Terms of Service)
PDMA-compliant interaction classification framework
Anthropic Enterprise API (zero data retention)
Business Associate Agreement available
"Your data never leaves your isolated environment. We do not train any model on your data — ever. That's in the contract, not just the pitch deck."
— MedAptive AI Security Commitment

Built by people who lived the problem.

15 years of Medical Affairs field experience, translated into the platform we wish had existed.

CEO
Founder & CEO
Medical Affairs · Product Vision
15 years as a Medical Science Liaison across oncology, rare disease, and pulmonology. Built and led MSL field teams, drove KOL engagement strategy, and spent a career watching valuable field intelligence disappear before it reached leadership. MedAptive AI is the platform she built because it didn't exist.
15yr MSL Experience KOL Strategy Evidence Generation MA Operations
CSO
Co-Founder & Chief Strategy Officer
Strategy · Commercialization · Technology
Attorney and deal-maker with a career spanning M&A, private equity, and technology transactions. Has evaluated, structured, and scaled businesses across healthcare and technology sectors. Leads go-to-market strategy, commercial architecture, investor relationships, and partnership development at MedAptive AI.
M&A Private Equity Technology GTM Strategy

Ready to make your Medical Affairs team adaptive?

Schedule a personalized demo with our founding team. We'll walk you through the platform using your therapeutic area and real-world use cases.

Request a Demo →

🔒  Your information is never shared. We respond within 1 business day.